Report cover image

Hormonal Supplements Industry Research Report 2025

Publisher APO Research, Inc.
Published Jul 02, 2025
Length 137 Pages
SKU # APRC20092620

Description

Summary

According to APO Research, the global Hormonal Supplements market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.

North American market for Hormonal Supplements is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Hormonal Supplements is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Hormonal Supplements is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Hormonal Supplements include Novartis AG, Merck & Co., Pfizer Inc., Bayer AG, USANA Health Sciences, Thorne Research, Swanson Health Products, Suntory Holdings and Sisterly, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Hormonal Supplements, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hormonal Supplements.

The report will help the Hormonal Supplements manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

The Hormonal Supplements market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Hormonal Supplements market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Hormonal Supplements Segment by Company

Novartis AG
Merck & Co.
Pfizer Inc.
Bayer AG
USANA Health Sciences
Thorne Research
Swanson Health Products
Suntory Holdings
Sisterly
Nutrascriptives
NOW Foods
Nature's Way
Nature's Bounty Co.
Meiji Holdings Co.
MegaFood
Life Extension
Herbalife Nutrition
GlaxoSmithKline
Garden of Life
Hormonal Supplements Segment by Type

Liquid
Tablets
Chewables
Capsules
Powders
Hormonal Supplements Segment by Application

Online Sales
Offline Sales
Hormonal Supplements Segment by Region

North America

United States
Canada
Mexico
Europe

Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific

China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America

Brazil
Argentina
Chile
Middle East Middle East & Africa
Africa

Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hormonal Supplements market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hormonal Supplements and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hormonal Supplements.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Hormonal Supplements manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Hormonal Supplements by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Hormonal Supplements in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

137 Pages
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Hormonal Supplements Market Size (2020-2031)
2.2.2 Global Hormonal Supplements Sales (2020-2031)
2.2.3 Global Hormonal Supplements Market Average Price (2020-2031)
2.3 Hormonal Supplements by Type
2.3.1 Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
2.3.2 Liquid
2.3.3 Tablets
2.3.4 Chewables
2.3.5 Capsules
2.3.6 Powders
2.4 Hormonal Supplements by Application
2.4.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
2.4.2 Online Sales
2.4.3 Offline Sales
3 Market Competitive Landscape by Manufacturers
3.1 Global Hormonal Supplements Market Competitive Situation by Manufacturers (2020 Versus 2024)
3.2 Global Hormonal Supplements Sales (Tons) of Manufacturers (2020-2025)
3.3 Global Hormonal Supplements Revenue of Manufacturers (2020-2025)
3.4 Global Hormonal Supplements Average Price by Manufacturers (2020-2025)
3.5 Global Hormonal Supplements Industry Ranking, 2023 VS 2024 VS 2025
3.6 Global Manufacturers of Hormonal Supplements, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Hormonal Supplements, Product Type & Application
3.8 Global Manufacturers of Hormonal Supplements, Established Date
3.9 Global Hormonal Supplements Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Novartis AG
4.1.1 Novartis AG Company Information
4.1.2 Novartis AG Business Overview
4.1.3 Novartis AG Hormonal Supplements Sales, Revenue and Gross Margin (2020-2025)
4.1.4 Novartis AG Hormonal Supplements Product Portfolio
4.1.5 Novartis AG Recent Developments
4.2 Merck & Co.
4.2.1 Merck & Co. Company Information
4.2.2 Merck & Co. Business Overview
4.2.3 Merck & Co. Hormonal Supplements Sales, Revenue and Gross Margin (2020-2025)
4.2.4 Merck & Co. Hormonal Supplements Product Portfolio
4.2.5 Merck & Co. Recent Developments
4.3 Pfizer Inc.
4.3.1 Pfizer Inc. Company Information
4.3.2 Pfizer Inc. Business Overview
4.3.3 Pfizer Inc. Hormonal Supplements Sales, Revenue and Gross Margin (2020-2025)
4.3.4 Pfizer Inc. Hormonal Supplements Product Portfolio
4.3.5 Pfizer Inc. Recent Developments
4.4 Bayer AG
4.4.1 Bayer AG Company Information
4.4.2 Bayer AG Business Overview
4.4.3 Bayer AG Hormonal Supplements Sales, Revenue and Gross Margin (2020-2025)
4.4.4 Bayer AG Hormonal Supplements Product Portfolio
4.4.5 Bayer AG Recent Developments
4.5 USANA Health Sciences
4.5.1 USANA Health Sciences Company Information
4.5.2 USANA Health Sciences Business Overview
4.5.3 USANA Health Sciences Hormonal Supplements Sales, Revenue and Gross Margin (2020-2025)
4.5.4 USANA Health Sciences Hormonal Supplements Product Portfolio
4.5.5 USANA Health Sciences Recent Developments
4.6 Thorne Research
4.6.1 Thorne Research Company Information
4.6.2 Thorne Research Business Overview
4.6.3 Thorne Research Hormonal Supplements Sales, Revenue and Gross Margin (2020-2025)
4.6.4 Thorne Research Hormonal Supplements Product Portfolio
4.6.5 Thorne Research Recent Developments
4.7 Swanson Health Products
4.7.1 Swanson Health Products Company Information
4.7.2 Swanson Health Products Business Overview
4.7.3 Swanson Health Products Hormonal Supplements Sales, Revenue and Gross Margin (2020-2025)
4.7.4 Swanson Health Products Hormonal Supplements Product Portfolio
4.7.5 Swanson Health Products Recent Developments
4.8 Suntory Holdings
4.8.1 Suntory Holdings Company Information
4.8.2 Suntory Holdings Business Overview
4.8.3 Suntory Holdings Hormonal Supplements Sales, Revenue and Gross Margin (2020-2025)
4.8.4 Suntory Holdings Hormonal Supplements Product Portfolio
4.8.5 Suntory Holdings Recent Developments
4.9 Sisterly
4.9.1 Sisterly Company Information
4.9.2 Sisterly Business Overview
4.9.3 Sisterly Hormonal Supplements Sales, Revenue and Gross Margin (2020-2025)
4.9.4 Sisterly Hormonal Supplements Product Portfolio
4.9.5 Sisterly Recent Developments
4.10 Nutrascriptives
4.10.1 Nutrascriptives Company Information
4.10.2 Nutrascriptives Business Overview
4.10.3 Nutrascriptives Hormonal Supplements Sales, Revenue and Gross Margin (2020-2025)
4.10.4 Nutrascriptives Hormonal Supplements Product Portfolio
4.10.5 Nutrascriptives Recent Developments
4.11 NOW Foods
4.11.1 NOW Foods Company Information
4.11.2 NOW Foods Business Overview
4.11.3 NOW Foods Hormonal Supplements Sales, Revenue and Gross Margin (2020-2025)
4.11.4 NOW Foods Hormonal Supplements Product Portfolio
4.11.5 NOW Foods Recent Developments
4.12 Nature's Way
4.12.1 Nature's Way Company Information
4.12.2 Nature's Way Business Overview
4.12.3 Nature's Way Hormonal Supplements Sales, Revenue and Gross Margin (2020-2025)
4.12.4 Nature's Way Hormonal Supplements Product Portfolio
4.12.5 Nature's Way Recent Developments
4.13 Nature's Bounty Co.
4.13.1 Nature's Bounty Co. Company Information
4.13.2 Nature's Bounty Co. Business Overview
4.13.3 Nature's Bounty Co. Hormonal Supplements Sales, Revenue and Gross Margin (2020-2025)
4.13.4 Nature's Bounty Co. Hormonal Supplements Product Portfolio
4.13.5 Nature's Bounty Co. Recent Developments
4.14 Meiji Holdings Co.
4.14.1 Meiji Holdings Co. Company Information
4.14.2 Meiji Holdings Co. Business Overview
4.14.3 Meiji Holdings Co. Hormonal Supplements Sales, Revenue and Gross Margin (2020-2025)
4.14.4 Meiji Holdings Co. Hormonal Supplements Product Portfolio
4.14.5 Meiji Holdings Co. Recent Developments
4.15 MegaFood
4.15.1 MegaFood Company Information
4.15.2 MegaFood Business Overview
4.15.3 MegaFood Hormonal Supplements Sales, Revenue and Gross Margin (2020-2025)
4.15.4 MegaFood Hormonal Supplements Product Portfolio
4.15.5 MegaFood Recent Developments
4.16 Life Extension
4.16.1 Life Extension Company Information
4.16.2 Life Extension Business Overview
4.16.3 Life Extension Hormonal Supplements Sales, Revenue and Gross Margin (2020-2025)
4.16.4 Life Extension Hormonal Supplements Product Portfolio
4.16.5 Life Extension Recent Developments
4.17 Herbalife Nutrition
4.17.1 Herbalife Nutrition Company Information
4.17.2 Herbalife Nutrition Business Overview
4.17.3 Herbalife Nutrition Hormonal Supplements Sales, Revenue and Gross Margin (2020-2025)
4.17.4 Herbalife Nutrition Hormonal Supplements Product Portfolio
4.17.5 Herbalife Nutrition Recent Developments
4.18 GlaxoSmithKline
4.18.1 GlaxoSmithKline Company Information
4.18.2 GlaxoSmithKline Business Overview
4.18.3 GlaxoSmithKline Hormonal Supplements Sales, Revenue and Gross Margin (2020-2025)
4.18.4 GlaxoSmithKline Hormonal Supplements Product Portfolio
4.18.5 GlaxoSmithKline Recent Developments
4.19 Garden of Life
4.19.1 Garden of Life Company Information
4.19.2 Garden of Life Business Overview
4.19.3 Garden of Life Hormonal Supplements Sales, Revenue and Gross Margin (2020-2025)
4.19.4 Garden of Life Hormonal Supplements Product Portfolio
4.19.5 Garden of Life Recent Developments
5 Global Hormonal Supplements Market Scenario by Region
5.1 Global Hormonal Supplements Market Size by Region: 2020 VS 2024 VS 2031
5.2 Global Hormonal Supplements Sales by Region: 2020-2031
5.2.1 Global Hormonal Supplements Sales by Region: 2020-2025
5.2.2 Global Hormonal Supplements Sales by Region: 2026-2031
5.3 Global Hormonal Supplements Revenue by Region: 2020-2031
5.3.1 Global Hormonal Supplements Revenue by Region: 2020-2025
5.3.2 Global Hormonal Supplements Revenue by Region: 2026-2031
5.4 North America Hormonal Supplements Market Facts & Figures by Country
5.4.1 North America Hormonal Supplements Market Size by Country: 2020 VS 2024 VS 2031
5.4.2 North America Hormonal Supplements Sales by Country (2020-2031)
5.4.3 North America Hormonal Supplements Revenue by Country (2020-2031)
5.4.4 United States
5.4.5 Canada
5.4.6 Mexico
5.5 Europe Hormonal Supplements Market Facts & Figures by Country
5.5.1 Europe Hormonal Supplements Market Size by Country: 2020 VS 2024 VS 2031
5.5.2 Europe Hormonal Supplements Sales by Country (2020-2031)
5.5.3 Europe Hormonal Supplements Revenue by Country (2020-2031)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.5.9 Spain
5.5.10 Netherlands
5.5.11 Switzerland
5.5.12 Sweden
5.5.13 Poland
5.6 Asia Pacific Hormonal Supplements Market Facts & Figures by Country
5.6.1 Asia Pacific Hormonal Supplements Market Size by Country: 2020 VS 2024 VS 2031
5.6.2 Asia Pacific Hormonal Supplements Sales by Country (2020-2031)
5.6.3 Asia Pacific Hormonal Supplements Revenue by Country (2020-2031)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 Taiwan
5.6.10 Southeast Asia
5.7 South America Hormonal Supplements Market Facts & Figures by Country
5.7.1 South America Hormonal Supplements Market Size by Country: 2020 VS 2024 VS 2031
5.7.2 South America Hormonal Supplements Sales by Country (2020-2031)
5.7.3 South America Hormonal Supplements Revenue by Country (2020-2031)
5.7.4 Brazil
5.7.5 Argentina
5.7.6 Chile
5.8 Middle East and Africa Hormonal Supplements Market Facts & Figures by Country
5.8.1 Middle East and Africa Hormonal Supplements Market Size by Country: 2020 VS 2024 VS 2031
5.8.2 Middle East and Africa Hormonal Supplements Sales by Country (2020-2031)
5.8.3 Middle East and Africa Hormonal Supplements Revenue by Country (2020-2031)
5.8.4 Egypt
5.8.5 South Africa
5.8.6 Israel
5.8.7 Türkiye
5.8.8 GCC Countries
6 Segment by Type
6.1 Global Hormonal Supplements Sales by Type (2020-2031)
6.1.1 Global Hormonal Supplements Sales by Type (2020-2031) & (Tons)
6.1.2 Global Hormonal Supplements Sales Market Share by Type (2020-2031)
6.2 Global Hormonal Supplements Revenue by Type (2020-2031)
6.2.1 Global Hormonal Supplements Sales by Type (2020-2031) & (US$ Million)
6.2.2 Global Hormonal Supplements Revenue Market Share by Type (2020-2031)
6.3 Global Hormonal Supplements Price by Type (2020-2031)
7 Segment by Application
7.1 Global Hormonal Supplements Sales by Application (2020-2031)
7.1.1 Global Hormonal Supplements Sales by Application (2020-2031) & (Tons)
7.1.2 Global Hormonal Supplements Sales Market Share by Application (2020-2031)
7.2 Global Hormonal Supplements Revenue by Application (2020-2031)
7.2.1 Global Hormonal Supplements Sales by Application (2020-2031) & (US$ Million)
7.2.2 Global Hormonal Supplements Revenue Market Share by Application (2020-2031)
7.3 Global Hormonal Supplements Price by Application (2020-2031)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Hormonal Supplements Value Chain Analysis
8.1.1 Hormonal Supplements Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Hormonal Supplements Production Mode & Process
8.2 Hormonal Supplements Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Hormonal Supplements Distributors
8.2.3 Hormonal Supplements Customers
9 Global Hormonal Supplements Analyzing Market Dynamics
9.1 Hormonal Supplements Industry Trends
9.2 Hormonal Supplements Industry Drivers
9.3 Hormonal Supplements Industry Opportunities and Challenges
9.4 Hormonal Supplements Industry Restraints
10 Report Conclusion
11 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.